Bionano Genomics Inc. (BNGO)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMEX $
1. 15
-0.02
-1.7094%
$
13.2M Market Cap
- P/E Ratio
- Div Yield
71,000 Volume
-6.61 Eps
$ 1.17
Previous Close 
Want to track BNGO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)
Bionano Genomics, Inc. (NASDAQ:BNGO ) Canaccord Genuity 44th Annual Growth Results Conference August 13, 2024 3:30 PM ET Company Participants Erik Holmlin - President and Chief Executive Officer Conference Call Participants Kyle Mikson - Canaccord Genuity Kyle Mikson Hi. Welcome to the Canaccord Genuity Global Growth Conference.
Seekingalpha | 1 year ago
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why
Bionano Genomics (BNGO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks | 1 year ago
3 Sorry Healthcare Stocks to Sell in May While You Still Can
Healthcare stocks often hold significant potential due to the constant demand for medical advancements. However, not all companies in this sector are poised for growth.
Investorplace | 2 years ago
